Who founded Ultima Genomics?

Ultima Genomics was founded by Gilad Almogy in 2016.

Who are Ultima Genomics's investors?

Ultima Genomics's investors include aMoon, Andreessen Horowitz, General Atlantic, Khosla Ventures, Lightspeed Venture Partners, Playground Global, Potentum Partners, Founders Fund.

How much funding has Ultima Genomics raised?

Ultima Genomics has disclosed $600M raised across 1 of its 2 known rounds.

Ultima Genomics

Founded 2016 · 308 employees on LinkedIn · 8 known investors

Find your way into Ultima Genomics

Paths you didn't know you had: your email and LinkedIn already hold routes to the Ultima Genomics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Ultima Genomics develops genomic sequencing technology to scale omics information for advances in biology and human health improvements.

Biotech Deep Tech Healthtech Medical Devices

Founders & leadership

Ultima Genomics was founded in 2016 by Gilad Almogy.

Gilad Almogy Founder and CEOHe previously founded and led Cogenra Solar and spent more than a decade at Applied Materials, where he served as Senior Vice President, Corporate Vice President, and General Manager of the Wafer Inspection division. His semiconductor career began at Orbot Instruments, where he managed wafer inspection R&D before the company's acquisition by Applied Materials.

Investors · 8

aMoonlisted by aMoonRa'anana

How we know: aMoon's portfolio page · funding news · Not right? Tell us

Andreessen Horowitzlisted by Andreessen HorowitzMenlo Park · $500K – $50M

How we know: a16z's portfolio · funding news · Not right? Tell us

General Atlanticlisted by General AtlanticNew York · $10M – $1B

How we know: funding news · generalatlantic.com · Not right? Tell us

Khosla Ventureslisted by Khosla VenturesMenlo Park · $100K – $20M

How we know: Khosla Ventures's portfolio page · funding news · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Lightspeed Venture Partnerslisted by Lightspeed Venture PartnersMenlo Park · $1M – $5M

How we know: Lightspeed Venture Partners's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Playground Globallisted by Playground GlobalPalo Alto · $1M – $20M

How we know: Playground Global's portfolio page · funding news · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Potentum Partnerslisted by Potentum PartnersMelbourne

How we know: Potentum Partners's portfolio page · Not right? Tell us

Founders FundreportedSan Francisco · $500K – $5M

How we know: funding news · Not right? Tell us

Funding

SEC filings, press & company announcements

$600M disclosed across 1 of 2 rounds · 2022

$600MraisedMay 2022 · 2 sources
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 5

IDbyDNAScalable, high throughput DNA sequencing platforms.

SequencingSequencing.com offers free storage of personal DNA data along with tools and reports that turn genetic testing results into health-related insights for consumers. The company addresses data storage, usability, and privacy challenges created by widely available consumer genetic testing.

10x Genomics10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers. The tools support applications in cancer, immunology, and neuroscience, enabling gene expression and multiomic profiling of cell surface protein, intracellular protein, and CRISPR guides.

GenewizGENEWIZ provides sequencing, synthesis, and molecular biology services for research, clinical, and therapeutic applications, serving academic institutions, biotech companies, and pharmaceutical organizations.

AgilentAgilent manufactures laboratory instruments, software, reagents, and consumables for pharmaceutical, diagnostics, clinical research, and applied markets including chemicals, food, and environmental sectors. The company operates through three segments: Life Sciences and Diagnostics Markets (which includes contract manufacturing services for oligonucleotide therapeutics and pathology solutions), Agilent CrossLab (providing lab services and automation), and Applied Markets (offering analytical instruments and software).

Companies working in the same space as Ultima Genomics.

In the news

Ultima Genomics claims $100 full genome sequencing after stealth $600M raisetechcrunch.com · Jun 2022

With $600M in Funding, Ultima is Removing Cost Barriers to Genomic Research - BioSpacebiospace.com · May 2022

Ultima Genomics Delivers the $100 Genomeprnewswire.com · May 2022

Frequently asked questions

What does Ultima Genomics do?: Ultima Genomics develops genomic sequencing technology to scale omics information for advances in biology and human health improvements.
Who founded Ultima Genomics?: Ultima Genomics was founded by Gilad Almogy in 2016.
Who are Ultima Genomics's investors?: Ultima Genomics's investors include aMoon, Andreessen Horowitz, General Atlantic, Khosla Ventures, Lightspeed Venture Partners, Playground Global, Potentum Partners, Founders Fund.
How much funding has Ultima Genomics raised?: Ultima Genomics has disclosed $600M raised across 1 of its 2 known rounds.